Furthermore, GBP1 reduces radioresistance of two human oral and liver cancer cell lines and correlates with better prognosis in melanoma but with poorer prognosis in human glioblastoma (15–21), (iii) GBP4 inhibits innate responses to viral infection (22) but lacks known tumor related functions to date. Here, GBP4 is linked to melanoma.